Autopsy report · NCT01638260
GLP-1 and Non-exercise Activity Thermogenesis in RHZ
Cause of deathSlow enrollment
“Terminated because of insufficient number of subjects included.”
Life of this trial
- Registered 3 months before it started.
- Ran for about 1 year 1 month before it stopped.
- 22 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Maastricht University Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Liraglutide; NEAT
- Participants
- 22
- Sites
- 1
- Countries
- Netherlands
Trials that died the same way
- The Role of Splinting in Fingertip Injuries
“Very few subjects were enrolled. Therefore, the study was terminated.” - Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP
“Terminated due to no new subject enrollment during the last 3 year period.” - Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer
“Terminated due to lack of efficacy” - Evaluation of Safety and Efficacy of the EndoLift Liver Retractor
“The study was terminated. Six subjects were consented \& all were withdrawn before any study activities took place.” - Treatment of West Nile Virus With MGAWN1
“Early termination due to the inability to enroll (13 of 120 subjects enrolled)”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.